KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ·Healthcare·Biotechnology
$27.00
—
Mkt Cap $1.44B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (9 analysts)
$28.50
Range $27.00 – $32.00
Implied Upside
+5.6%
Consensus $28.50 vs current $27.00
NASDAQ·Healthcare·Biotechnology
$27.00
—
Mkt Cap $1.44B
Buy
5
Hold
2
Sell
0
Price Target (9 analysts)
$28.50
Range $27.00 – $32.00
+5.6%
Consensus $28.50 vs current $27.00